Health Technology/clinical-trials

Remote Programming of Cardiac Implantable Electronic Devices: French Study Demonstrates Feasibility for Australian Practice

247 Health News Editorial

·

21 May 2026

·

3 min read

·clinical-trials

A completed French study demonstrates the feasibility of remote programming for cardiac implantable electronic devices, potentially transforming follow-up care for pacemaker and ICD patients. This research addresses critical access challenges in cardiac device management, particularly relevant for Australian patients in rural and remote areas.

Originally reported by ClinicalTrials.gov

References

  1. 1.University Hospital Bordeaux. (2022). Remote Programming of Cardiac Implantable Electronic Device. ClinicalTrials.gov. NCT05366660. https://clinicaltrials.gov/study/NCT05366660
  2. 2.Australian Institute of Health and Welfare. (2023). Cardiovascular disease in Australia. AIHW. https://www.aihw.gov.au/reports/heart-stroke-vascular-diseases/cardiovascular-health-compendium
  3. 3.Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., ... & ESC Scientific Document Group. (2021). 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation. European Heart Journal, 42(5), 373-498. https://doi.org/10.1093/eurheartj/ehaa612
  4. 4.Varma, N., Cygankiewicz, I., Turakhia, M. P., Heidbuchel, H., Hu, Y., Chen, L. Y., ... & Steinberg, J. S. (2021). 2021 ISHNE/HRS/EHRA/APHRS collaborative statement on mHealth in Arrhythmia Management. Heart Rhythm, 18(4), 611-632. https://doi.org/10.1016/j.hrthm.2021.04.023
  5. 5.Slotwiner, D., Varma, N., Akar, J. G., Annas, G., Beardsall, M., Fogel, R. I., ... & Zipes, D. P. (2015). HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. Heart Rhythm, 12(7), e69-e100. https://doi.org/10.1016/j.hrthm.2015.05.008
  6. 6.Kusumoto, F. M., Schoenfeld, M. H., Barrett, C., Edgerton, J. R., Ellenbogen, K. A., Gold, M. R., ... & Varosy, P. D. (2019). 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay. Circulation, 140(8), e382-e482. https://doi.org/10.1161/CIR.0000000000000628
Share:XLinkedIn
2

247 Health News Editorial

247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service